ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 28

Role of Microrna 455 Networks in Mesenchymal Cell Differentiation and Osteoarthritis

Fumiaki Ayabe1, Shigeru Miyaki2, Diana Brinson1, Satoshi Yamashita3, Hiroyuki Nakahara1, Koji Otabe1, Stuart Duffy1, Shawn Grogan4, Shuji Takada3, Martin K. Lotz1 and Hiroshi Asahara5, 1Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, 2Department of Orthopaedic Surgery, Hiroshima University, Hiroshima, Japan, 3Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo, Japan, 4The Scripps Research Institute, La Jolla, CA, 5Molecular & Experimental Med, The Scripps Research Institute, La Jolla, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cartilage, inflammation and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: The objectives of this study were to identify cartilage specific microRNAs (miRNAs, miR-) that are regulated by SOX9 and are increased in chondrogenesis, to determine changes in osteoarthritic (OA) cartilage, and to investigate the role of miR-455-5p and miR-455-3p (miR-455s) in human chondrocytes.

Methods: To identify miRNAs specifically expressed in chondrocytes, we performed microarray and quantitative polymerase chain reaction (qPCR) on cultured mouse chondrocytes using adenovirally induced SOX9 transcription. The expression of miR-455s was analyzed by qPCR on human articular chondrocytes, human mesenchymal stem cells (MSCs). The expression of miR-455s was monitored during chondrogenic differentiation of human MSCs in pellet cultures as well as in human articular cartilage from both normal and OA knee joints. We tested the effects of interleukin-1b (IL-1b) on miR-455s expression. Double-stranded miR-455s (ds-miR-455s) was transfected into chondrocytes to identify changes in gene expression associated with OA.

Results: The expression of miR-455s mirrors SOX9 expression, with large differences between human chondrocytes and human MSCs. During chondrogenesis, miR-455s expression in MSC cultures increased in parallel with the expression of SOX9, MAF and COL10A1. Normal human articular cartilage expressed miR-455s, with significant reduction in OA tissue. In vitro treatment of chondrocytes with IL-1b suppressed miR-455s expression. Transfection of chondrocytes with ds-miR-455s down-regulated expression of inflammatory genes.

Conclusion: This study shows that miR-455s expression is altered in concert with other chondrocyte differentiation-related expression patterns. The reduction in miR-455s expression in OA cartilage and in response to IL-1b may contribute to the abnormal gene expression pattern characteristic of OA.


Disclosure:

F. Ayabe,
None;

S. Miyaki,
None;

D. Brinson,
None;

S. Yamashita,
None;

H. Nakahara,
None;

K. Otabe,
None;

S. Duffy,
None;

S. Grogan,
None;

S. Takada,
None;

M. K. Lotz,
None;

H. Asahara,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-microrna-455-networks-in-mesenchymal-cell-differentiation-and-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology